Monday, April 18, 2016 3:00:45 PM
https://smithonstocks.com/relypsa-analyzing-march-results-of-the-veltassa-launch-rlyp-buy-17-60/
(Won't copy the subscription based article; SoS is one of my favorite sites)
Main ideas:
Strong momentum on small numbers for now, difficult to project for the next couple of years;
May 26th PDUFA for ZS-9 could turn into a catalyst depending on FDA's assessment.
Buy recommendation at current PPS
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM